A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.
Completed · Phase 3
Conditions studied: Pulmonary Disease, Chronic Obstructive
In brief
To evaluate changes in PaO2 following inhalation of Tiotropium by HandiHaler compared to Salmeterol MDI in patients with moderate to severe COPD.
Key facts
- Study ID
- NCT00274534
- Run by
- Boehringer Ingelheim
- People needed
- 36
- Starts
- 2000-12-01
- Expected to finish
- 2003-07-01
- Last updated by the study team
- 2013-11-05
Who can join
Age: 50 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Hines Veterans Administration Hospital — Hines, Illinois, United States
- Hunter Holmes McGuire Medical Center — Richmond, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.